Hikma Pharmaceuticals USA INC Recalls
2 recalls on record in the United States
drugs: 2
drugs
Class II
2026-05-06
Hikma Pharmaceuticals USA INC recalls Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx onl
This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
View recall details →
drugs
Class II
2026-09-02
Hikma Pharmaceuticals USA INC. recalls Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (N
Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
View recall details →